Hernia clinical trials at UCSD
2 research studies open to eligible people
De-implementing Inhaled Nitric Oxide for Congenital Diaphragmatic Hernia
open to eligible people ages 0 months to 1 month
The purpose of this study is to determine if de-implementation of inhaled nitric oxide (iNO) in the post-natal resuscitation/stabilization phase affects the composite outcome of extracorporeal life support (ECLS) use and/or mortality, as well as ECLS use, mortality, and/or oxygenation in congenital diaphragmatic hernia (CDH) newborns and to establish the cost-effectiveness of de-implementing iNO as a therapy in the postnatal resuscitation/stabilization phase of CDH management, which will be assessed as the incremental health system costs (savings) per prevented ECLS use and/or death.
San Diego, California and other locations
GORE® ENFORM Biomaterial Product Study
open to eligible people ages 18 years and up
A prospective, retrospective, non-randomized, multicenter study with two independent hernia study cohorts (Ventral / Incisional Hernia Repair and Diaphragmatic / Hiatal Hernia Repair). The primary objective of this study is to collect GORE® ENFORM Biomaterial product commercial-use data on device functional performance and short-term patient experience.
San Diego, California and other locations
Our lead scientists for Hernia research studies include Ryan Broderick, MD.
Last updated: